A. Kolkmeyer

Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile.

M. Kreuter, W. Berdel, T. Spieker, 2010, International journal of oncology.

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors

W. Berdel, H. Serve, C. Müller-Tidow, 2006, Molecular Cancer Therapeutics.

Heterogeneity of radiation- and TNF-alpha-induced programmed cell death in carcinoma, sarcoma and lymphoma cell lines.

N. Willich, B. Greve, S. Könemann, 2010, Anticancer research.

Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level

N. Willich, A. Schuck, S. Könemann, 2005, Apoptosis.

Changed adhesion molecule profile of Ewing tumor cell lines and xenografts under the influence of ionizing radiation.

N. Willich, A. Schuck, R. Diallo, 2004, Anticancer research.

Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile

N. Willich, A. Schuck, R. Diallo, 2003, International journal of radiation biology.

Time‐ and dose‐dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation

N. Willich, A. Schuck, R. Diallo, 2003, International journal of radiation biology.

Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes

W. Hiddemann, J. Greve, R. Doornbos, 1996 .

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.

Walter Heindel, Thorsten Persigehl, Torsten Kessler, 2009, Blood.

DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.

W. Hiddemann, J. Harbott, W. Ludwig, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells

W. Berdel, H. Serve, T. Büchner, 2005, Annals of Hematology.